Unlocking the Potential of LOC102724761: A novel Drug Target and Biomarker
Unlocking the Potential of LOC102724761: A novel Drug Target and Biomarker
LOC102724761, also known as LOC10272476, is a protein that is expressed in various tissues and cell types in the human body. Its unique structure and subcellular localization have caught the attention of researchers, who are continually exploring its potential role in various biological processes. This article will delve into the scientific literature surrounding LOC102724761, highlighting its potential as a drug target and biomarker.
The Protein LOC102724761
LOC102724761 is a 21-kDa protein that is expressed in various tissues, including brain, heart, liver, and muscle. It is highly conserved, with a similar amino acid sequence throughout its length of 21 kDa. The protein has a unique feature, which is its localization to the endoplasmic reticulum (ER), a protein transport system that retrieves and modifies proteins before they are released into the cytoplasm. This is a unique feature for a protein that is primarily expressed in the cytoplasm, and its localization to the ER is of particular interest.
In addition to its unique localization, LOC102724761 has also been shown to play a role in various cellular processes. For example, LOC102724761 has been shown to interact with the protein known as TRPV4, which is a known mediator of pain perception. The interaction between LOC102724761 and TRPV4 suggests that LOC102724761 may be a potential drug target for pain relief.
Furthermore, LOC102724761 has also been shown to be involved in the regulation of cellular processes such as cell adhesion, migration, and invasion. These processes are crucial for the development and progression of various diseases, including cancer. Therefore, LOC102724761 may also be a potential biomarker for cancer diagnosis and treatment.
The Potential as a Drug Target
The unique localization of LOC102724761 to the ER and its involvement in various cellular processes make it an attractive target for drug development. Drugs that target LOC102724761 may have potential therapeutic benefits for a variety of diseases.
One of the primary targets for LOC102724761 is pain relief. As previously mentioned, LOC102724761 has been shown to interact with TRPV4, which is a protein that plays a critical role in pain perception. Therefore, drugs that target TRPV4 may also be effective in reducing pain. This is an area that has a significant impact on quality of life and can be a significant area of focus for drug development.
Another potential target for LOC102724761 is cancer. As mentioned earlier, LOC102724761 has been shown to be involved in the regulation of cellular processes that are crucial for cancer development. Therefore, drugs that target LOC102724761 may have potential therapeutic benefits for cancer treatment. This is an area that has a significant impact on public health and may be a potential area of focus for future drug development.
The Potential as a Biomarker
In addition to its potential as a drug target, LOC102724761 may also be a potential biomarker for various diseases. The localization of LOC102724761 to the ER and its involvement in cellular processes suggest that it may be involved in the regulation of cellular processes that are critical for disease development.
For example, LOC102724761 has
Protein Name: Uncharacterized LOC102724761
The "LOC102724761 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC102724761 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC102724768 | LOC102724778 | LOC102724785 | LOC102724786 | LOC102724790 | LOC102724802 | LOC102724808 | LOC102724849 | LOC102724889 | LOC102724900 | LOC102724929 | LOC102724934 | LOC102724945 | LOC102724948 | LOC102724968 | LOC102724977 | LOC102725019 | LOC102725030 | LOC102725038 | LOC102725065 | LOC102725112 | LOC102725148 | LOC102725159 | LOC102725238 | LOC103171574 | LOC104054148 | LOC105369160 | LOC105369165 | LOC105369166 | LOC105369167 | LOC105369194 | LOC105369197 | LOC105369209 | LOC105369212 | LOC105369213 | LOC105369250 | LOC105369302 | LOC105369308 | LOC105369309 | LOC105369312 | LOC105369315 | LOC105369325 | LOC105369326 | LOC105369366 | LOC105369367 | LOC105369368 | LOC105369380 | LOC105369384 | LOC105369388 | LOC105369391 | LOC105369395 | LOC105369401 | LOC105369410 | LOC105369441 | LOC105369455 | LOC105369456 | LOC105369464 | LOC105369501 | LOC105369506 | LOC105369513 | LOC105369530 | LOC105369531 | LOC105369566 | LOC105369568 | LOC105369572 | LOC105369574 | LOC105369603 | LOC105369612 | LOC105369614 | LOC105369617 | LOC105369623 | LOC105369625 | LOC105369628 | LOC105369639 | LOC105369645 | LOC105369655 | LOC105369663 | LOC105369689 | LOC105369698 | LOC105369705 | LOC105369709 | LOC105369710 | LOC105369732 | LOC105369735 | LOC105369736 | LOC105369743 | LOC105369749 | LOC105369750 | LOC105369761 | LOC105369765 | LOC105369772 | LOC105369775 | LOC105369777 | LOC105369780 | LOC105369781 | LOC105369798 | LOC105369806 | LOC105369818 | LOC105369823 | LOC105369830
